<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02206217</url>
  </required_header>
  <id_info>
    <org_study_id>H-ZG3B</org_study_id>
    <nct_id>NCT02206217</nct_id>
  </id_info>
  <brief_title>Myopia Control With the Multi-segment Lens</brief_title>
  <official_title>The Clinical Trial of Myopia Control in Schoolchildren Using the Multi-segment (MS) Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the Multiple-Segment (MS) lens can slow myopia
      progression in Hong Kong schoolchildren.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MS lens is a novel lens designed in attempt to slow myopia progression. It is a multifocal
      spectacle lens which corrects distance refractive error and at the same time produces myopic
      defocus images on the retina for all distances. The myopic defocus aims at slowing down
      myopia progression. The purpose of this study is to investigate if the MS lens can slow
      myopia progression in Hong Kong Chinese schoolchildren. The subjects will be randomly
      assigned to either treatment group (wear MS lenses) or control group (wear ordinary single
      vision lenses). Their cycloplegic refraction and axial length will be monitored every six
      months over 2 years. The changes in refractive errors and axial length in two groups will be
      compared.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cycloplegic refraction</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Axial length</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">183</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Single vision spectacle lens</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Single vision lens with power for correcting distance refraction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple-Segment spectacle lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A multifocal spectacle lens that corrects distance refraction and provides myopic defocus at the same time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multiple-Segment spectacle lens</intervention_name>
    <description>A multifocal spectacle lens that corrects distance refraction and provides myopic defocus images simultaneously. The myopic defocus aims at slowing down myopia progression.</description>
    <arm_group_label>Multiple-Segment spectacle lens</arm_group_label>
    <other_name>MS lens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age at enrolment: 8-13 year

          -  Spherical equivalent refractions (SER): -1.00 to -5.00 Dioptres (D)

          -  Astigmatism and anisometropia of 1.50 D or less

          -  Spectacle corrected monocular logMAR visual acuity: 0 or better

          -  Parents' understanding and acceptance of random allocation of grouping

        Exclusion Criteria:

          -  any ocular and systemic abnormalities might affect visual functions or refractive
             development

          -  prior treatment of myopic control, e.g. drugs, orthokeratology, progressive addition
             lenses, bifocal lenses, drugs (e.g. atropine), etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carly SY Lam, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chi ho To, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Myopia Research, The Hong Kong Polytechnic University</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre for Myopia Research, The Hong Kong Polytechnic University</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2014</study_first_submitted>
  <study_first_submitted_qc>July 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2014</study_first_posted>
  <last_update_submitted>March 7, 2017</last_update_submitted>
  <last_update_submitted_qc>March 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Carly Lam</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>May 16, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

